stars 1 stars 2 stars 3

Scanogen is a molecular diagnostic company developing systems to read the biomolecular information of body fluids with the goal of improving health care. The Company has developed Single MOLecule Tethering (SMOLT), a proprietary technology for rapid and ultra-sensitive detection of biomolecules. The Company is using this technology to develop a simple-to-use and sample-to-answer diagnostic platform. Scanogen has received NIH grants totaling $9.5 million to develop its diagnostic assays and it is currently focused on two areas: Point-of-care diagnosis and bloodstream infection detection.

Scanogen Inc. Questions

The Scanogen Inc. annual revenue was $1 million in 2026.

Alfredo Celedon is the Founder and CEO of Scanogen Inc..

20 people are employed at Scanogen Inc..

Scanogen Inc. is based in Baltimore, Maryland.

The NAICS codes for Scanogen Inc. are [541, 54, 5417, 541714, 54171].

The SIC codes for Scanogen Inc. are [87, 873].

Top Scanogen Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users